Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Monte Rosa Therapeutics Inc

GLUE
Current price
5.11 USD -0.28 USD (-5.19%)
Last closed 5.39 USD
ISIN US61225M1027
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 317 297 376 USD
Yield for 12 month +20.52 %
1Y
3Y
5Y
10Y
15Y
GLUE
21.11.2021 - 28.11.2021

Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops MRT-2359, an orally bioavailable molecular glue degrader targeting the translation termination factor protein GSPT1 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of systemic and central nervous system autoimmune diseases; and MRT-8102 for the treatment of IL-1"/NLRP3 driven inflammatory diseases. It also develops CDK2 to treat ovarian, uterine, and breast cancers. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts. Address: 321 Harrison Avenue, Boston, MA, United States, 02118

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.83 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

+4 695 000 USD

Last Quarter

+1 064 000 USD

Current Year

-6 222 000 USD

Last Year

-8 559 000 USD

Current Quarter

+2 635 000 USD

Last Quarter

-833 000 USD

Key Figures GLUE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -131 783 000 USD
Operating Margin TTM -695.25 %
PE Ratio
Return On Assets TTM -27.99 %
PEG Ratio
Return On Equity TTM -59.51 %
Wall Street Target Price 15.83 USD
Revenue TTM 5 759 000 USD
Book Value 3.66 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.22 USD
Diluted Eps TTM -2.22 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GLUE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GLUE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GLUE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 17.2684
Price Sales TTM 55.0959
Enterprise Value EBITDA -0.781
Price Book MRQ 1.4123

Financials GLUE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GLUE

For 52 weeks

2.44 USD 8.84 USD
50 Day MA 5.29 USD
Shares Short Prior Month 3 061 103
200 Day MA 5.35 USD
Short Ratio 13.71
Shares Short 3 273 659
Short Percent 9.75 %